News
抄読会要旨 吉田知栄子
2023年度実績
Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation. J Allergy Clin Immunol. 2023 Feb 3:S0091-6749(23)00144-6.
熊本大学 呼吸器内科